2027 FDA Insurance 
The Checkup by Singlecare
AUGUST 20, 2024
Without insurance, the cost of Stiolto Respimat can be over $600 per month. For many people, the retail price of Stiolto Respimat can make getting treatment difficult without insurance coverage. Currently, there is no generic version of Stiolto Respimat approved by the Food and Drug Administration (FDA). mcg tiotropium and 2.5
The Checkup by Singlecare
JANUARY 3, 2023
Is Eucrisa covered by insurance? | How much does Eucrisa cost without insurance? | How to get Eucrisa without insurance. Eucrisa is a FDA-approved nonsteroidal prescription drug. The soonest date a generic may come on the market is between 2027 and 2030, but this is not certain. Is Eucrisa covered by insurance?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
OCTOBER 9, 2024
While Lumigan is a 0.01% solution of bimatoprost and no generic product is manufactured at this concentration, patents on Lumigan expire in 2025 and 2027, so there may be a generic option approved by the Food and Drug Administration (FDA) thereafter. Is Lumigan covered by insurance? How much does Lumigan cost without insurance?
The Checkup by Singlecare
JANUARY 18, 2024
Is Nexplanon covered by insurance? | How much does Nexplanon cost without insurance? | How to get Nexplanon without insurance Nexplanon is a brand-name prescription birth control implant that does not contain estrogen. in 2027 and other countries in 2025, when a generic version may be approved.
The Checkup by Singlecare
JANUARY 10, 2023
Is Spiriva Respimat covered by insurance? | How much does Spiriva Respimat cost without insurance? | How to get Spiriva Respimat without insurance. Spiriva Respimat is also FDA-approved as a long-term maintenance treatment for asthma in adults and children six years or older. Is Spiriva Respimat covered by insurance?
PharmaShots
FEBRUARY 22, 2023
A qualifying medication is prescribed by their healthcare provider The patients who have no insurance or have Medicare Part D Patients who are not enrolled in Medicaid, full Low-Income Subsidy, or Veterans (VA) benefits. The patient must-have commercial health insurance to use the savings card. Virgin Islands.
Pharmaceutical Technology
NOVEMBER 30, 2022
In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. The drug was approved to treat type 2 diabetes mellitus in May. Access to anti-obesity medications.
Expert insights. Personalized for you.
98 
Let's personalize your content